comparemela.com

Page 4 - Cancer Blood Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Change Makers: Elcin Barker Ergun on Healthcare Renaissance

WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.

United statesUnited kingdomBarker ergunElcin barker ergunJohn whyteMenarini groupMedical officer john whyteIm dr john whyteChange makersWestern worldHealthcare and medical technologyEalth and medical techEalth and med techEalth and medical technologyPractice managementPrimary care

Liquid Biopsy Shortens Time to NSCLC Treatment

Patients who underwent plasma ctDNA testing started therapy for advanced NSCLC earlier than those who underwent only tissue biopsy, but "plasma first does not mean plasma only," the authors say.

Neil osterweilMiguel garcPrincess margaret cancer centrePrincess margaret cancer foundationDivision of medical oncology hematology fellowship awardInivata incYale cancer centerSmilow cancerLung health foundation breathe better breathingOne grant award programHematology fellowship awardDistrict lung cancer innovationLung cancerUng carcinomaAncer lungLiquid biopsy

Liquid Biopsy Shows Big Promise in Oropharyngeal Cancer

The blood test could aid diagnosis and surveillance of HPV-associated oropharyngeal squamous cell carcinoma, new research shows.

New yorkUnited statesRocco ferrandinoMiriam langoNeck societyDepartment of headUniversity of texas md anderson cancer centerMount sinaiMedscape medicalNeck surgeryAmerican headCancer centerNt earsLiquid biopsyLuid biopsyLuid phase biopsy

Dr Amir shares new blood test could detect more than 50 cancer types

A new cancer blood test has shown real promise in a major NHS trial, according to researchers.

United statesAamir khanAmerican society of clinical oncologyAmerican societyClinical oncologyLancet oncologyCtp videoAutoplay videoNew cancer testCancer breakthroughHealth newsHealth latestCancer blood testBlood test could identify more than 50 cancersBlood test for cancerDr amir khan

Liquid Biopsy Assay Can Predict CRC Recurrence Early

Patients testing positive for any of six ctDNA biomarkers on the liquid biopsy assay had a substantially higher risk for colorectal cancer recurrence.

United statesSantiago de compostelaJuan ruiz baKevan morrisAjay goelShaobo moFudan university shanghai cancer centerUniversity of santiago de compostelaCity of hope comprehensive cancer centerUniversity of texas md anderson cancer centerCancer centerHope comprehensive cancer centerColorectal cancerDisease recurrenceLiquid biopsyLuid biopsy

vimarsana © 2020. All Rights Reserved.